Biosimilars: How investors can ‘fill the void’ to drive rapid market growth
Biosimilars is a fast-developing segment of biologics, with recent regulatory changes expected to address development challenges and stimulate market growth.
We work for public and private companies and investors, helping them understand the key commercial questions when growing, buying and selling businesses
Hospitals and clinics, mental health, dental, IVF, clinical labs, diagnostics, primary care, pharmacy, insurance, consumer healthcare and distribution.
Care homes, homecare, complex behavioural care, supported living, housing with care, retirement housing, fostering, SEN schools, children’s residential services, nurseries.
Reagents, tools, diagnostics, medical devices and implants, hospital equipment, healthcare IT.
Generic and speciality pharma manufacturing, CRO/CMO, CDMO, bioinformatics, medical communications.
Our specialisation means we provide unparalleled depth and insight into healthcare, social care & education, pharma and life sciences.
Biosimilars is a fast-developing segment of biologics, with recent regulatory changes expected to address development challenges and stimulate market growth.
In the second of our two-part series on vendor commercial due diligence (VCDD), Adam Scott,
senior partner, and Abhishek Patel, engagement manager, at Mansfield Advisors, discuss how
to effectively engage with advisors to create a compelling narrative for buyers
Ellie Wee, junior analyst, and Victor Chua, senior partner look at how private ophthalmology has increased volumes without compromising on quality
We support the leading private equity, corporate, and institutional investors to maximise value throughout the transaction journey. Post-acquisition, we partner with management teams to plan and execute value-creating strategies.
Our experienced team have supported more than 120 projects and worked on transactions worth over £5bn.
We offer an outside-in perspective, data analytics and experience in successful strategies.
Investors in Healthcare is a digital resource delivering sector focussed news, data and analysis. The journal covers M&A deals, capital raising and investment rounds in the healthcare and life science sector of Europe and the Middle East. It also publishes news stories and research on the latest developments in the market and runs interviews with some of the key players shaping the future of the industry.
To find out more about how Mansfield Advisors can assist your organisation, please contact us to arrange a meeting, virtual or in person.